Method for purifying proteins from membrane protein complexes
Artificial polymers maintain membrane protein complexes during elution, enabling the purification of intact complexes and individual proteins through pH-controlled processes, facilitating the understanding of protein relationships.
Patent Information
- Application Number
- JP2021069637
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-04-16
- Publication Date
- 2024-11-14
- Estimated Expiration
- 2041-04-16
AI Technical Summary
Conventional methods using surfactants to elute membrane proteins from biological membranes disrupt the protein complexes, making it difficult to maintain their structural integrity and understand protein relationships.
Using artificial polymers, particularly amphiphilic polymers, to elute membrane protein complexes in their intact state, followed by a pH-controlled process to bind to antibodies, elute under alkaline conditions, and remove the polymer under acidic conditions.
Enables the purification of membrane protein complexes in their native state, allowing for the identification of protein interactions and individual purification of proteins within the complex.
Smart Images

Figure 0007583410000002 
Figure 0007583410000003 
Figure 0007583410000004
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for purifying a protein from a membrane protein complex. [Background technology]
[0002] When eluting membrane proteins from biological membranes, methods using surfactants have been widely used. Summary of the Invention [Problem to be solved by the invention]
[0003] However, as a result of extensive research by the present inventors, it was found that the conventional and widely used method of eluting proteins using surfactants destroys the structure of protein complexes that have formed on membranes or the like, resulting in the proteins being separated and eluted as individual proteins. An object of the present invention is to solve the above-mentioned problem newly discovered by the inventors, and to provide a method for eluting a membrane protein complex in its complex state even when a protein complex is formed, and for purifying a protein derived from the membrane protein complex. [Means for solving the problem]
[0004] As a result of intensive research into the above-mentioned problems, the present inventors came up with the idea of using an artificial polymer instead of a surfactant. As shown in FIG. 1, when a surfactant is used, the structure of the membrane protein complex on the biological membrane is destroyed, and it is separated into individual proteins and eluted. Therefore, it is difficult to clarify the relationship between the proteins. On the other hand, it was found that when an artificial polymer, particularly an amphipathic polymer, is used instead of a surfactant, the membrane protein complex can be eluted in the state of a complex with the lipids of the membrane. This is presumably because the molecular weight of the artificial polymer is larger than that of the surfactant, and the membrane protein complex can be eluted in the state of a complex without destroying the structure of the complex.
[0005] Furthermore, the present inventors faced the problem of how to purify the eluted membrane protein complex when the membrane protein complex was eluted using an artificial polymer. Since antibodies are often used to purify proteins, we investigated purification using antibodies, that is, a method of binding only a specific protein to an antibody, separating it from other proteins, and then eluting the specific protein bound to the antibody. Although the use of an acidic solution is recommended for eluting proteins bound to antibodies, when an artificial polymer was used, elution of the protein could not be confirmed even when eluted with an acidic solution.
[0006] When faced with this fact, the present inventors initially thought that it would be impossible to purify proteins using antibodies when artificial polymers were used. However, to their surprise, they discovered that proteins could be eluted by elution under conditions above a specific pH (alkaline conditions), rather than under the conventional acidic conditions. This was a surprising discovery. On the other hand, when they attempted to elute proteins from antibodies under alkaline conditions, they found that although the elution itself was possible, when they tried to remove the artificial polymer in the next step, a new problem occurred: the removal efficiency was significantly reduced under alkaline conditions.
[0007] Therefore, in the process of removing the artificial polymer from the solution containing the eluted protein and artificial polymer, it was found that the artificial polymer can be efficiently removed by carrying out the process under acidic conditions that destabilize the artificial polymer.
[0008] That is, the present invention was completed based on the above-mentioned findings, and relates to a method for purifying a protein derived from a membrane protein complex, comprising a protein binding step of binding a membrane protein complex eluted from a membrane to an antibody using an artificial polymer, a protein elution step of eluting the membrane protein complex bound to the antibody in the protein binding step under a pH condition of 6.0 or higher, and an artificial polymer removal step of removing the artificial polymer from the membrane protein complex eluted in the protein elution step by solvent extraction under a pH condition of 7.0 or lower.
[0009] The artificial polymer is preferably an amphiphilic polymer.
[0010] The artificial polymer is preferably a polymer having units derived from maleic acid.
[0011] The artificial polymer is preferably Poly(styrene-maleic acid) (SMA) or Poly(diisobutylene-maleic acid) (DIBMA).
[0012] In the protein elution step, it is preferable to elute the membrane protein complex under conditions of pH 9.0 or higher.
[0013] The membrane protein complex is preferably a membrane protein complex derived from a single membrane.
[0014] The single membrane is preferably made of rubber particles.
[0015] The membrane protein complex preferably contains a protein belonging to the prenyltransferase family.
[0016] The membrane protein complex preferably contains a protein belonging to the cis-prenyltransferase family.
[0017] The membrane protein complex preferably contains a protein belonging to the cis-prenyltransferase family derived from a plant belonging to the genus Hevea or Taraxacum. Effect of the Invention
[0018] According to the present invention, the method for purifying a membrane protein complex-derived protein includes a protein binding step of binding a membrane protein complex eluted from a membrane to an antibody using an artificial polymer, a protein elution step of eluting the membrane protein complex bound to the antibody by the protein binding step under a condition of pH 6.0 or higher, and an artificial polymer removal step of removing the artificial polymer by performing solvent extraction on the membrane protein complex eluted by the protein elution step under a condition of pH 7.0 or lower. Therefore, even if a protein complex is formed, the membrane protein complex can be eluted in the complex state, and the membrane protein complex-derived protein can be purified. By eluting the membrane protein complex in the complex state, highly related proteins can be eluted together as a complex, and further, it is possible to purify the proteins individually from the eluted membrane protein complex. As a result, if there are multiple purified proteins, it is found that these proteins form a complex on the membrane. In this way, the method of the present invention can also obtain information such as which proteins form a complex with which proteins on the membrane. [Brief description of the drawings]
[0019] [Figure 1] FIG. 1 is a diagram showing an example of the elution of proteins and the like when a surfactant is used and when an artificial polymer is used. [Diagram 2] FIG. 1 is a diagram showing an example of the elution of proteins and the like when an artificial polymer is used. [Diagram 3] FIG. 1 is a diagram showing the results of Comparative Example 1, Examples 1 and 2. [Figure 4] FIG. 1 is a diagram showing the results of Comparative Example 2 and Example 3. [Diagram 5]FIG. 1 shows experimental results illustrating differences due to pH conditions. [Figure 6] FIG. 1 shows experimental results indicating the difference between a non-specific antibody and a specific antibody. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0020] The method for purifying a membrane protein complex-derived protein of the present invention includes a protein binding step of binding the membrane protein complex eluted from the membrane to an antibody using an artificial polymer, a protein elution step of eluting the membrane protein complex bound to the antibody in the protein binding step under a pH of 6.0 or higher, and an artificial polymer removal step of removing the artificial polymer from the membrane protein complex eluted in the protein elution step by solvent extraction under a pH of 7.0 or lower. Each of the steps may be carried out a plurality of times, and other steps may be carried out between each of the steps.
[0021] (Protein extraction process) First, the protein extraction process will be described. In the protein extraction process, the membrane protein complex is eluted from the membrane using an artificial polymer, which allows highly related proteins to be eluted from the membrane in the form of a complex. In this specification, the state of a complex refers to a state in which a group of proteins that form homo- or heteromultimers of dimers or more are bound to membrane-derived lipids.
[0022] The artificial polymer is not particularly limited as long as it is a chemically synthesized polymer, but for example, an amphiphilic polymer can be suitably used. A straight-chain polymer is also preferred. These may be used alone or in combination of two or more kinds. The amphiphilic polymer is not particularly limited as long as it has both hydrophilic and hydrophobic sites in the polymer, and examples thereof include polymers in which hydrophobic monomers and hydrophilic monomers are polymerized randomly or in blocks, polymers in which monomers having both hydrophilic and hydrophobic groups are polymerized, polymers in which hydrophilic side chains are bonded to hydrophobic main chains, and polymers in which hydrophobic side chains are bonded to hydrophilic main chains. These may be used alone or in combination of two or more. Among them, polymers in which hydrophobic monomers and hydrophilic monomers are polymerized randomly or in blocks are preferred.
[0023] Examples of polymers in which hydrophobic monomers and hydrophilic monomers are polymerized randomly or in a block manner include polymers having units derived from maleic acid, such as Poly(styrene-maleic acid) (SMA, styrene-maleic acid polymer), Poly(diisobutylene-maleic acid) (DIBMA, diisobutylene-maleic acid polymer), isoprene-maleic acid polymer, and butadiene-maleic acid polymer; Polymers having units derived from fumaric acid, such as styrene fumaric acid polymers, diisobutylene fumaric acid polymers, isoprene fumaric acid polymers, and butadiene fumaric acid polymers; Polymers having units derived from citraconic acid, such as styrene citraconic acid polymers, diisobutylene citraconic acid polymers, isoprene citraconic acid polymers, and butadiene citraconic acid polymers; Polymers having units derived from mesaconic acid, such as styrene mesaconic acid polymers, diisobutylene mesaconic acid polymers, isoprene mesaconic acid polymers, and butadiene mesaconic acid polymers; Examples of the polymer include a polymer having a unit derived from aconitic acid, such as a styrene aconitic acid polymer, a diisobutylene aconitic acid polymer, an isoprene aconitic acid polymer, and a butadiene aconitic acid polymer. These may be used alone or in combination of two or more. Among these, a polymer having a unit derived from maleic acid is preferred, and Poly(styrene-maleic acid) (SMA) and Poly(diisobutylene-maleic acid) (DIBMA) are more preferred. [ka]
[0024] The weight average molecular weight (Mw) of the artificial polymer is preferably 3000 or more, more preferably 5000 or more, even more preferably 8000 or more, and particularly preferably 10000 or more, and the upper limit is not particularly limited, but is preferably 100000 or less, more preferably 50000 or less, even more preferably 30000 or less, and particularly preferably 15000 or less. Within the above range, the effect can be more preferably obtained. In particular, when Mw is equal to or greater than the lower limit, it becomes possible to more preferably elute the membrane protein complex in the form of a complex by collecting highly related proteins together. In this specification, the weight average molecular weight (Mw) can be determined by converting it into standard polystyrene based on the measured value obtained by gel permeation chromatography (GPC) (GPC-8000 series manufactured by Tosoh Corporation, detector: differential refractometer, column: TSKGEL SUPERMULTIPORE HZ-M manufactured by Tosoh Corporation).
[0025] The membrane is not particularly limited as long as it is a membrane in which a membrane protein complex exists, and examples thereof include biological membranes. Examples of biological membranes include bimembranes (lipid bimembranes) such as cell membranes, mitochondrial outer membranes, mitochondrial inner membranes, nuclear membranes, endoplasmic reticulum membranes, Golgi membranes, lysosomal membranes, synaptic vesicle membranes, endosomal membranes, and peroxisome membranes; and single membranes (lipid single membranes) such as rubber particles and oil droplets. These may be used alone or in combination of two or more. Among these, single membranes are preferred, and rubber particles are more preferred. That is, the membrane protein complex is preferably a membrane protein complex derived from a single membrane, and more preferably a membrane protein complex derived from a rubber particle.
[0026] When proteins are eluted from a bilayer membrane using an artificial polymer, even if only part of the membrane is eluted, as shown in Figure 2, the hydrophobic parts of the lipids are present inside the membrane, so it is assumed that no structural problems will arise. On the other hand, when eluting a protein from a single membrane using an artificial polymer, it was thought that the hydrophobic part of the lipid may appear on the surface after elution, which would cause instability, unlike in the case of a bilayer membrane. However, in reality, even when eluting a protein from a single membrane using an artificial polymer, the feared instability was not observed. Such a discovery that there is no instability even when eluting a protein from a single membrane using an artificial polymer is a surprising discovery that exceeds the predictions of those skilled in the art.
[0027] The term "membrane protein complex" refers to a membrane protein that is attached to a membrane such as a biological membrane, and in which a plurality of proteins associate to form a complex. Here, in this specification, a protein being attached to a membrane means that all or a part of the protein is incorporated into the membrane or inserted into the membrane structure of the membrane, but is not limited thereto and also means that the protein is localized on the membrane surface or inside, etc. Furthermore, a protein that forms a complex with a membrane-bound protein and exists on the membrane as a complex is also included in the conceptual scope of being bound to the membrane.
[0028] Examples of membrane proteins that form membrane protein complexes include proteins that are partially enclosed in the membrane, proteins that span the membrane (transmembrane proteins), and proteins that temporarily bind to these integral membrane proteins.
[0029] Specific examples of the membrane protein include receptors, channels, transporters, pumps, enzymes, etc. The membrane protein may be a membrane protein whose function is to be elucidated, but since the biosynthetic pathway of natural rubber has many unknown aspects, it is preferable to target a protein bound to rubber particles where natural rubber biosynthesis is expected to take place. In particular, a protein belonging to the prenyltransferase family, which is considered to play a central role in the biosynthesis of natural rubber but whose function has not yet been fully elucidated, is preferable, a protein belonging to the cis-type prenyltransferase family is more preferable, and a protein belonging to the cis-type prenyltransferase family derived from a plant belonging to the Hevea or Taraxacum genus is even more preferable. That is, the membrane protein complex preferably contains a protein belonging to the prenyltransferase family, more preferably contains a protein belonging to the cis-type prenyltransferase family, and even more preferably contains a protein belonging to the cis-type prenyltransferase family derived from a plant belonging to the Hevea or Taraxacum genus.
[0030] Proteins belonging to the prenyltransferase family include proteins belonging to the cis-prenyltransferase family and proteins belonging to the trans-prenyltransferase family, with proteins belonging to the cis-prenyltransferase family being preferred.
[0031] The origin of the protein belonging to the prenyltransferase family and the protein belonging to the cis-prenyltransferase (CPT) family is not particularly limited and may be derived from a microorganism, an animal, or a plant. However, it is preferable that the protein is derived from a plant, more preferably from a plant belonging to at least one genus selected from the group consisting of the genera Hevea, Sonchus, Taraxacum, and Parthenium, even more preferably from a plant belonging to the genus Hevea or Taraxacum, particularly preferably from Hevea brasiliensis or Taraxacum kosher, and most preferably from Hevea brasiliensis.
[0032] The plant is not particularly limited, and examples thereof include the genus Hevea such as Hevea brasiliensis; the genus Sonchus such as Sonchus oleraceus, Sonchus asper, and Sonchus brachyotus; Solidago altissima, Solidago virgaurea subsp. asiatica, Solidago virgaurea subsp. leipcarpa, Solidago virgaurea subsp. leipcarpa f. paludosa, Solidago virgaurea subsp. gigantea, and Solidago gigantea Ait. var. leiophylla. Solidago genus such as Helianthus annuus, Helianthus argophyllus, Helianthus atrorubens, Helianthus debilis, Helianthus decapetalus, Helianthus giganteus, Helianthus giganteus, Taraxacum venustum H. Koidz, Taraxacum hondoense Nakai, Taraxacum platycarpum Dahlst, Taraxacum japonicum, Taraxacum officinale genus Taraxacum, such as Taraxacum koksaghyz, Taraxacum brevicorniculatum, fig (Ficus carica), rubber tree (Ficus elastica), ficus pumila L., and Ficus erecta Thumb.), Ficus ampelas Burm.f., Ficus benguetensis Merr., Ficus irisana Elm., Ficus microcarpa Lf., Ficus septica Burm.f., Ficus benghalensis, and other genus Ficus; Parthenium argentatum, Parthenium hysterophorus, ragweed, and other genus Parthenium; Lactuca sativa, Ficus benghalensis, Arabidopsis thaliana, and other lettuce.
[0033] In this specification, a protein belonging to the prenyltransferase (CPT) family is an enzyme that catalyzes a reaction to elongate the chain length of an isoprenoid compound. In addition, in this specification, a protein belonging to the trans prenyltransferase (CPT) family is an enzyme that catalyzes a reaction that elongates the chain length of an isoprenoid compound in the trans form. In addition, in this specification, a protein belonging to the cis-prenyltransferase (CPT) family is an enzyme that catalyzes a reaction that extends the chain length of an isoprenoid compound in a cis form. A characteristic of proteins belonging to the CPT family is that they have an amino acid sequence contained in the Cis IPPS domain (NCBI Accession No. cd00475).
[0034] In this specification, the term "isoprenoid compound" refers to a compound having an isoprene unit (C5H8). In addition, the term "cis-isoprenoid" refers to a compound having an isoprenoid compound in which the isoprene unit is bonded in a cis-form, and examples of such compounds include cis-farnesyl diphosphate, undecaprenyl diphosphate, and natural rubber.
[0035] Next, a method for eluting a membrane protein complex from a membrane using an artificial polymer in the protein extraction step will be described.
[0036] The method for eluting the membrane protein complex from the membrane using the artificial polymer is not particularly limited as long as it is a method that can elute the membrane protein complex from the membrane using the artificial polymer, and for example, the artificial polymer may be brought into contact with the membrane in a solution. Specifically, the artificial polymer and the membrane may be mixed in a solution.
[0037] The pH of the solution is preferably 6.0 or more, more preferably 7.0 or more, and is preferably 10.0 or less, more preferably 9.0 or less, and even more preferably 8.0 or less. Within the above range, the effect tends to be more suitably obtained. In this specification, pH is a value measured at 25°C. In the present specification, the pH of the solution may be adjusted using a buffer solution, and the buffer solution to be used is not particularly limited.
[0038] The temperature of the solution during mixing is preferably 1° C. or higher, more preferably 2° C. or higher, and is preferably 15° C. or lower, more preferably 10° C. or lower, and even more preferably 5° C. or lower. Within the above range, the effect tends to be more favorably obtained.
[0039] The mixing time is preferably 10 minutes or more, more preferably 20 minutes or more, and even more preferably 30 minutes or more, and although there is no particular upper limit, it is preferably 6 hours or less, more preferably 3 hours or less, and even more preferably 1 hour or less. When it is within the above range, the effect tends to be more suitably obtained.
[0040] The concentration of the artificial polymer in the solution is preferably 0.5 g / L or more, more preferably 3.0 g / L or more, even more preferably 5.0 g / L or more, particularly preferably 8.0 g / L or more, and most preferably 10.0 g / L or more, and is preferably 100 g / L or less, more preferably 80.0 g / L or less, even more preferably 50.0 g / L or less, particularly preferably 30.0 g / L or less, and most preferably 15.0 g / L or less. Within the above range, the effect tends to be more favorably obtained.
[0041] In the protein extraction process, the artificial polymer and the membrane are mixed in a solution, and then the protein solution and the membrane are separated. Methods for separating the protein solution and the membrane include, for example, centrifugation and filtration. The solution after separation is then used as the protein solution for the next process.
[0042] (Protein purification carrier preparation process) As described above, the method allows highly related proteins to be eluted together as a complex by eluting the membrane protein complex in the state of the complex, and furthermore, by purifying the proteins individually from the eluted membrane protein complex, if a plurality of proteins are purified, it is found that these proteins form a complex on the membrane. Thus, the method allows information such as which proteins form a complex with which other proteins on the membrane to be obtained. Therefore, the protein from which information is desired may be further purified from the proteins contained in the protein solution obtained by the protein extraction step.
[0043] Specifically, for example, a support for protein purification may be prepared according to a known method so that a target protein can be purified. The method for preparing the support for protein purification is not particularly limited, and a person skilled in the art can easily prepare the support once the target protein is determined.
[0044] Specifically, an antibody capable of specifically binding to the protein of interest may be bound to a carrier such as beads, and the antibody may be prepared, for example, by treating serum with the protein of interest. The carrier is not particularly limited, and examples thereof include agarose-based resins (such as Affi-gel (registered trademark)), methacrylate-based resins (such as TOYOPEARL (registered trademark)), magnetic beads (such as Dynabeads (registered trademark)), etc. These may be used alone or in combination of two or more kinds.
[0045] (Protein binding step) In the protein binding step, the membrane protein complex eluted from the membrane using the artificial polymer is bound to an antibody, thereby making it possible to separate the target protein complex from the membrane protein complex eluted from the membrane using the artificial polymer. Specifically, the protein about which information is to be obtained or a protein complex containing the protein about which information is to be obtained can be separated from the membrane protein complexes eluted from the membrane using an artificial polymer by using a protein purification carrier to which an antibody corresponding to the protein about which information is to be obtained is bound, the carrier being prepared in the protein purification carrier preparation process in order to purify the protein contained in the protein solution obtained by the protein extraction process.
[0046] In the protein binding step, for example, the protein solution obtained in the protein extraction step may be mixed with the support for protein purification to which the antibody is bound. As a result, the target protein that can specifically bind to the antibody bound to the support for protein purification and the protein complex containing the target protein bind to the support for protein purification, while other proteins do not bind to the support for protein purification, and therefore the target protein and the protein complex containing the target protein can be separated from the other proteins.
[0047] The pH of the solution is preferably 6.0 or more, more preferably 6.5 or more, even more preferably 7.0 or more, and is preferably 10.0 or less, more preferably 9.0 or less, even more preferably 8.0 or less. Within the above range, the effect tends to be more suitably obtained.
[0048] The temperature of the solution during mixing is preferably 1° C. or higher, more preferably 2° C. or higher, and is preferably 15° C. or lower, more preferably 10° C. or lower, and even more preferably 5° C. or lower. Within the above range, the effect tends to be more favorably obtained.
[0049] The mixing time is preferably 10 minutes or more, more preferably 20 minutes or more, and even more preferably 30 minutes or more, and although there is no particular upper limit, it is preferably 3 hours or less, more preferably 2 hours or less, and even more preferably 1 hour or less. When it is within the above range, the effect tends to be more suitably obtained.
[0050] In the protein binding step, the protein solution obtained in the protein extraction step is mixed with the antibody-bound protein purification support, and the solution is recovered as a flow-through fraction, and the protein purification support separated from the solution is provided to the next step. Methods for separating the solution from the carrier for protein purification include, for example, centrifugation and filtration. Furthermore, the protein purification support separated from the solution may be washed with a buffer solution or the like, if necessary, before being subjected to the next step.
[0051] (Protein elution step) In the protein elution step, the membrane protein complex bound to the antibody in the protein binding step is eluted under conditions of pH 6.0 or higher. This allows the membrane protein complex bound to the antibody to be separated from the protein purification support. In particular, elution under alkaline conditions tends to be more effective. This is presumably because elution under alkaline conditions allows the protein to be eluted in a state in which the artificial polymer is stabilized. On the other hand, the protein is not eluted under acidic conditions. This is presumably because elution under acidic conditions causes the artificial polymer to be insolubilized.
[0052] Specifically, for example, the support for protein purification obtained in the protein binding step may be stirred in a solution having a pH of 6.0 or higher (preferably 8.0 or higher), whereby the target protein bound to the support for protein purification or a protein complex containing the target protein can be eluted from the support for protein purification.
[0053] The pH of the solution is preferably 7.0 or more, more preferably 8.0 or more, even more preferably 9.0 or more, particularly preferably 10.0 or more, and most preferably 10.5 or more, and although there is no particular upper limit, it is preferably 12.0 or less, more preferably 11.5 or less. Within the above range, the effect tends to be more suitably obtained.
[0054] The temperature of the solution during mixing is preferably 1° C. or higher, more preferably 2° C. or higher, and is preferably 15° C. or lower, more preferably 10° C. or lower, and even more preferably 5° C. or lower. Within the above range, the effect tends to be more favorably obtained.
[0055] The mixing time is preferably 3 minutes or more, more preferably 5 minutes or more, and even more preferably 10 minutes or more, and although there is no particular upper limit, it is preferably 1 hour or less, more preferably 40 minutes or less, and even more preferably 20 minutes or less. When it is within the above range, the effect tends to be more suitably obtained.
[0056] The solution may contain a surfactant. When a surfactant is contained, the antibody is eluted together with the target protein or a protein complex containing the target protein. When a surfactant is used, the protein can be eluted not only under alkaline conditions but also under neutral conditions. When a surfactant is used, heat treatment may be performed as necessary. Heat treatment conditions include, for example, 80 to 100°C and 5 to 15 minutes.
[0057] As the surfactant, anionic surfactants such as carboxylic acid, sulfonic acid, sulfate, or phosphate; nonionic surfactants such as polyoxyalkylene ether, polyoxyalkylene ester, polyhydric alcohol fatty acid ester, sugar fatty acid ester, alkyl polyglycoside, or polyoxyalkylene polyglucoside; amphoteric surfactants such as amino acid, betaine, imidazoline, or amine oxide. These may be used alone or in combination of two or more. Among them, anionic surfactants are preferred.
[0058] In the protein elution step, the protein purification support obtained in the protein binding step is stirred in a solution having a pH of 6.0 or more, and then the solution and the protein purification support are separated. Methods for separating the solution and the protein purification support include, for example, centrifugation and filtration. The solution after separation is then provided to the next step as a protein elution fraction.
[0059] (Artificial polymer removal process) In the artificial polymer removal step, the membrane protein complex eluted in the protein elution step is subjected to solvent extraction under conditions of pH 7.0 or less to remove the artificial polymer. This makes it possible to remove the artificial polymer and lipid from the membrane protein complex eluted in the protein elution step, and further improves the efficiency of protein extraction, making it easier to detect the protein. Usually, during this operation, the membrane protein complex changes from a complex state to a state in which each protein exists individually. This is presumably because the artificial polymer and lipid that contributed to maintaining the complex state are removed.
[0060] Specifically, for example, the protein eluted fraction solution obtained in the protein elution step may be subjected to solvent extraction under conditions of pH 7.0 or less to separate the protein, the artificial polymer, and the lipid.
[0061] There are no limitations on the extraction method, but ether extraction or monohydric alcohol / halogenated hydrocarbon extraction is preferred, monohydric alcohol / halogenated hydrocarbon extraction is more preferred, and methanol / chloroform extraction is even more preferred.
[0062] The pH of the solution is preferably 6.5 or less, more preferably 6.0 or less, and even more preferably 5.0 or less, and although there is no particular lower limit, it is preferably 1.0 or more, more preferably 2.0 or more, and even more preferably 2.8 or more. Within the above range, the effect tends to be more suitably obtained.
[0063] The temperature of the solution during mixing is preferably 4° C. or higher, more preferably 10° C. or higher, and even more preferably 15° C. or higher, and is preferably 25° C. or lower, and more preferably 20° C. or lower. Within the above range, the effect tends to be more favorably obtained.
[0064] The extraction time is not particularly limited, but is, for example, 5 to 10 minutes.
[0065] In the artificial polymer removal step, after performing solvent extraction, the protein from which the artificial polymer and lipids have been removed is recovered, and the resulting protein is then subjected to the next step.
[0066] (Protein detection process) In the protein detection step, the protein obtained in the artificial polymer removal step is detected, which makes it possible to detect and identify the protein obtained in the artificial polymer removal step.
[0067] The detection of proteins is not particularly limited, and examples thereof include electrophoresis (e.g., gel electrophoresis), immunochemical detection methods (e.g., Western blot analysis, ELISA, RIA), protein arrays (e.g., planar and bead-based systems), chromatographic separation methods, activity assays, mass spectrometry, etc. These may be used alone or in combination of two or more. Among them, electrophoresis is preferred, and SDS-PAGE is more preferred.
[0068] The protein detection step allows for qualitative analysis of proteins, thereby providing information such as which proteins form complexes with which other proteins on the membrane.
[0069] The method of the present invention makes it possible to purify not only artificially overexpressed proteins and proteins tagged for easy purification, but also natural proteins. That is, it is preferable that the membrane protein complex-derived protein does not have a purification tag, and more preferably does not have a histidine tag. EXAMPLES
[0070] The present invention will be specifically described based on examples, but the present invention is not limited to these examples.
[0071] [Preparation of rubber particles] Rubber particles were prepared from Hevea latex by five stages of centrifugation. A latex solution was prepared by adding 100 mL of 1 M Tris buffer (pH 7.5) containing 20 mM dithiothreitol (DTT) to 900 mL of Hevea latex. The resulting latex solution was centrifuged stepwise at different centrifugation speeds of 1000 x g, 2000 x g, 8000 x g, 20000 x g, and 50000 x g. All centrifugations were performed at 4 °C for 45 min. The fractionated rubber particles were resuspended in 1.5 volumes of 100 M Tris buffer (pH 7.5) containing 2 mM dithiothreitol (DTT).
[0072] [Protein extraction process] (dissolving membrane protein complexes from rubber particles) 500μL of ultrapure water was added to 50mg of poly(diisobutylene-maleic acid) (DIBMA) (Mw=12,000, Cube Biotech) to prepare a 10% DIBMA solution. 100μL of 20% rubber particle solution, 50μL of 10% DIBMA solution, and 250μL of 100mM Tris-HCl Buffer (pH7.5) were mixed (total 400μL. DIBMA final concentration 12.5g / L) and mixed by inversion at 4℃ for 1 hour. After the elution procedure, ultracentrifugation was performed at 1,000,000×g for 45 minutes at 4° C. to separate the protein solution from the rubber particles, and the aqueous layer after separation was used as the protein solution.
[0073] [Protein purification carrier (protein purification beads) preparation process] The beads used for protein purification were prepared by coupling antibodies to Dynabeads M-270 Epoxy according to the instructions for the Dynabeads Co-Immunoprecipitation Kit (Veritas Corporation). Two types of antibodies were prepared for coupling: an antibody (Pre-antibody) purified from rabbit serum before antigen treatment, and an antibody (HRT1 antibody) purified from rabbit serum antigen-treated with HRT1 peptide (a protein belonging to the cis-type prenyltransferase family derived from Hevea brasiliensis), and each was bound to beads (Pre-antibody-bound beads, HRT1 antibody-bound beads).
[0074] [Protein binding step (protein purification (co-immunoprecipitation))] To 1.5 mg of the antibody-bound beads prepared above, 200 μL of protein solution in which the protein had been dissolved from the rubber particles and 200 μL of 100 mM Tris-HCl (pH 7.5) were added, and the mixture was mixed by inversion at 4°C for 1 hour to bind the protein and antibody. After mixing by inversion for 1 hour, the aqueous layer was collected as the flow-through fraction. The remaining antibody-bound beads were washed three times with 400 μL of 100 mM Tris-HCl (pH 7.5), and then washed with 400 μL of 100 mM Tris-HCl (pH 7.5) containing 0.02% Tween 20 by inversion for 10 minutes.
[0075] [Protein elution step] Comparative Example 1 To the washed beads, 60 μL of 50 mM glycine buffer (pH 2.8) was added, and the mixture was mixed by inversion for 10 minutes at 4° C. After mixing, the aqueous layer was used as the protein elution fraction. Example 1 60 μL of 500 mM NH4OH (pH 11.0) was added to the washed beads, and the mixture was mixed by inversion for 10 minutes at 4° C. After mixing, the aqueous layer was used as the protein elution fraction. Example 2 60 μL of 1×SDS sample buffer (62.5 mM Tris-HCl (pH 6.8), 50 mM dithiothreitol (DTT), 2% sodium dodecylsulphate (SDS), 5% sucrose, 0.005% bromophenol blue (BPB)) was added to the washed beads, and the beads were heat-treated at 98°C for 10 minutes. After heat treatment, the aqueous layer was used as the protein elution fraction.
[0076] [Artificial polymer removal process] Comparative Example 1 To remove artificial polymers and lipids, 60 μL of the eluted protein solution was extracted with methanol / chloroform. 240 μL (four times the amount of the sample) of cold methanol solution was added to 60 μL of the protein solution and mixed by vortexing. Furthermore, 60 μL (the same amount as the sample) of cold chloroform solution was added and mixed by vortexing. Finally, 180 μL (three times the amount of the sample) of cold ultrapure water was added and mixed by vortexing. After separating into two layers by centrifugation at 15,000 × g for 3 minutes, the aqueous layer (upper layer) was removed. 240 μL (four times the amount of the sample) of cold methanol solution was added again to the remaining organic layer (lower layer) and protein layer and mixed. The solution was centrifuged once at 5,000 × g for 1 minute, and then centrifuged at 20,000 × g for 5 minutes. After removing the organic layer after centrifugation, the remaining protein pellet was completely dried. The dried protein pellet was redissolved in 30 μL of 1×SDS sample buffer. All of the above treatments were carried out at 18° C. After redissolution, the protein pellet was heat-treated at 98° C. for 10 minutes. (Examples 1 and 2) 1M acetate buffer (pH 3.5) was added to the eluted protein solution to acidify the solution, and then methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except for the pH.
[0077] [Protein detection step (silver staining)] Protein detection was confirmed by SDS-PAGE. A 15% acrylamide gel was used as the separation gel. Protein staining was performed by silver staining using Sil-Best Stain One (Nacalai Tesque, Inc.). The results are shown in Figure 3.
[0078] In Comparative Example 1, no protein elution was observed in the eluted fractions when immunoprecipitation was performed with either the Pre antibody or the HRT antibody (Figure 3(a)). On the other hand, in Example 1, protein elution was observed in both immunoprecipitation with the Pre antibody and the HRT antibody (Figure 3(b)). Furthermore, since a difference was observed in the proteins eluted with the Pre antibody and the HRT antibody, it is believed that co-immunoprecipitation with the HRT antibody had occurred. Furthermore, in Example 2, protein elution was observed in both immunoprecipitation with the Pre antibody and the HRT antibody (Figure 3(c)). However, in this case, the antibody used for purification was also eluted together.
[0079] The patterns of proteins eluted with the Pre antibody and the HRT antibody are different in Examples 1 and 2. This demonstrates that any protein can be purified using the antibody. In addition, not just one type of protein was eluted, but bands representing two or more types of proteins were confirmed. If the proteins were eluted individually using the artificial polymer, only one type of band (HRT only) would be detected, so the fact that multiple bands were eluted indicates that the proteins were eluted in a complex state. From these findings, it was found that proteins could be solubilized in a complex state from rubber particles (single membrane) using artificial polymers, and that complexes containing any protein could be purified using antibodies.
[0080] Further investigation of Comparative Example 1 confirmed that protein was not eluted from the beads under the condition of pH 2.8.
[0081] [Effect of pH on the artificial polymer removal process (comparison experiment of methanol / chloroform extraction efficiency with pH)] (Comparative Example 2 (Alkaline Conditions)) 150 μL of 500 mM NH4OH (pH 11.0) was added to 50 μL of the protein solution dissolved from the rubber particles described above, and the solution was mixed with a vortex to adjust the pH to 11.0. After leaving it to stand for 5 minutes, methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except that the pH was different, to remove artificial polymers and lipids. The amount of protein was then confirmed by SDS-PAGE. The gel was stained with Coomassie Brilliant Blue (CBB). The results are shown in Figure 4. (Example 3 (acidic conditions)) 150 μL of 50 mM glycine-HCl buffer (pH 2.8) was added to 50 μL of the protein solution dissolved from the rubber particles described above, and the solution was mixed with a vortex to adjust the pH to 2.8. After leaving it to stand for 5 minutes, methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except that the pH was different, to remove artificial polymers and lipids. The amount of protein was then confirmed by SDS-PAGE. The gel was stained with Coomassie Brilliant Blue (CBB). The results are shown in Figure 4.
[0082] 4, even though the same procedure was performed using the same protein solution, protein was detected under acidic conditions (Example 3), whereas almost no protein was detected under alkaline conditions. This shows that it is better to make the solution acidic.
[0083] [Effect of pH on the artificial polymer removal process (Comparison experiment of methanol / chloroform extraction efficiency with pH (when the buffer composition is the same but only the pH is different))] In the previous comparative experiment, the reagents used to adjust the pH were different, and there was a risk of an effect due to the composition of the reagents. Therefore, the experiment was performed with the same composition of buffer solutions. (Comparative Example 3 (Alkaline Conditions)) 75 μL of 200 mM Tris-acetate buffer (pH 9.0) was added to 25 μL of the protein solution dissolved from the rubber particles described above, and the solution was mixed with a vortex to adjust the pH to 9.0. After leaving it to stand for 5 minutes, methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except that the pH was different, to remove artificial polymers and lipids. The amount of protein was then confirmed by SDS-PAGE. The gel was stained with Coomassie Brilliant Blue (CBB). The results are shown in Figure 5. (Example 4 (neutral conditions)) 75 μL of 200 mM Tris-acetate buffer (pH 7.0) was added to 25 μL of the protein solution dissolved from the rubber particles described above, and the solution was mixed with a vortex to adjust the pH to 7.0. After leaving it to stand for 5 minutes, methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except that the pH was different, to remove artificial polymers and lipids. The amount of protein was then confirmed by SDS-PAGE. The gel was stained with Coomassie Brilliant Blue (CBB). The results are shown in Figure 5. (Example 5 (acidic conditions)) 75 μL of 200 mM Trisi-acetate buffer (pH 3.0, 4.0, 5.0, 6.0) was added to 25 μL of the protein solution dissolved from the rubber particles described above, and the solution was mixed with a vortex to adjust the pH to 3.0, 4.0, 5.0, or 6.0, respectively. After leaving it to stand for 5 minutes, methanol / chloroform extraction was performed in the same manner as in Comparative Example 1, except that the pH was different, to remove artificial polymers and lipids. The amount of protein was then confirmed by SDS-PAGE. The gel was stained with Coomassie Brilliant Blue (CBB). The results are shown in Figure 5.
[0084] As can be seen from Figure 5, when methanol / chloroform extraction is performed under acidic to neutral conditions (pH 3.0 to 7.0), there is little change in the amount of protein. On the other hand, a decrease in the amount of protein was confirmed under alkaline conditions (pH 9.0). This is thought to be because the artificial polymer becomes unstable under acidic conditions, making the complex of the artificial polymer, lipids, and protein more susceptible to destruction, increasing the efficiency of methanol / chloroform extraction.
[0085] To confirm whether the target protein had been specifically purified from the eluted fraction, Western blotting was performed using HRT antibody. The results are shown in Figure 6. The protein solutions eluted from the Pre antibody and the HRT antibody were subjected to SDS-PAGE using a 15% acrylamide gel, and the proteins were transferred to a PVDF membrane using a Trans-Blot Turbo Transfer System (Bio Rad) at 25 V, 1.0 A, and 30 minutes. After transfer, the PVDF membrane was washed with PBS- and then blocked overnight at 4°C using PVDF Blocking Reagent for Can Get Signal (TOYOBO). After blocking, the PVDF membrane was washed with PBS-T, and then 2.5μL (2000-fold dilution) of 1mg / mL HRT antibody solution was added to 5mL of Solution1 for primary antibody solution of Can Get Signal Immunoreaction Enhancer Solution (TOYOBO) to permeate the PVDF membrane at room temperature for 10 minutes to perform the primary antibody reaction. After the primary antibody reaction, the PVDF membrane was washed again with PBS-T to wash away excess antibody. After washing, the PVDF membrane was permeated with 5 mL of Can Get Signal Immunoreaction Enhancer Solution (Solution 2 for secondary antibody) plus 0.5 μL (10,000-fold dilution) of H Anti-IgG (H+L Chain) (Rabbit) pAb-HRP Goat IgG antibody for 10 minutes at room temperature to perform the secondary antibody reaction. After the secondary antibody reaction, the PVDF membrane was washed again with PBS-T to wash away excess antibody. Antibodies were detected using Amersham ECL Prime Western blotting detection reagent, and luminescence due to horseradish peroxidase (HRP) bound to the secondary antibody was detected using a photosensitive film.
[0086] As shown in Figure 6, a specific band was detected only in the protein solution eluted from the HRT antibody, indicating that any protein can be purified according to purpose by using a specific antibody.
Claims
1. a protein binding step of binding the membrane protein complex eluted from the membrane to an antibody using an artificial polymer that is destabilized under a pH of 7.0 or less; a protein elution step of eluting the membrane protein complex bound to the antibody in the protein binding step under a condition of pH 6.0 or higher; an artificial polymer removal step of removing the artificial polymer from the membrane protein complex eluted in the protein elution step by performing solvent extraction under conditions of pH 7.0 or less; Including, The method for purifying a protein derived from a membrane protein complex, wherein the artificial polymer is an amphiphilic polymer.
2. The method for purifying a membrane protein complex-derived protein according to claim 1, wherein the artificial polymer is a polymer having a unit derived from maleic acid.
3. 2. The method for purifying a membrane protein complex-derived protein according to claim 1, wherein the artificial polymer is Poly(styrene-maleic acid) (SMA) or Poly(diisobutylene-maleic acid) (DIBMA).
4. 4. The method for purifying a membrane protein complex-derived protein according to claim 1, wherein the membrane protein complex is eluted under conditions of pH 9.0 or higher in the protein elution step.
5. 4. The method for purifying a membrane protein complex-derived protein according to claim 1, wherein the membrane protein complex is eluted using a surfactant in the protein elution step.
6. The method for purifying a protein derived from a membrane protein complex according to any one of claims 1 to 5, wherein the membrane protein complex is a membrane protein complex derived from a single membrane.
7. The method for purifying a protein derived from a membrane protein complex according to claim 6, wherein the single membrane is a rubber particle.
8. The method for purifying a protein derived from a membrane protein complex according to any one of claims 1 to 7, wherein the membrane protein complex contains a protein belonging to the prenyltransferase family.
9. The method for purifying a protein derived from a membrane protein complex according to any one of claims 1 to 8, wherein the membrane protein complex contains a protein belonging to the cis-prenyltransferase family.
10. 10. The method for purifying a protein derived from a membrane protein complex according to claim 1, wherein the membrane protein complex contains a protein belonging to a cis-prenyltransferase family derived from a plant belonging to the genus Hevea or Taraxacum.
Citation Information
Patent Citations
Immobilization of membrane proteins onto a support by amphiphilic substances
JP2010509602A
Surfactant Compounds - CLIP for Extraction of Membrane Proteins and Stabilization in Solution
JP2020510026A
Production method for rubber particles having membrane-binding protein bound thereto, production method for pneumatic tire, and production method for rubber product
WO2017002504A1
